News

Linda De Jesus, IDT Vice President and General Manager, Global Head of Commercial.
Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments ...
Prostate cancer is a significant health concern for men globally, with rising incidence and mortality rates. Early detection ...
Research from the NIH’s National Cancer Institute, an agency beleaguered by funding cuts and censorship, finds that ...
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...
An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.
The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.
Exposure to air pollution, other contaminants and traditional herbal medicines may be contributing to the development of lung ...
Panelists discuss that for patients with both ESR1 and PIK3CA mutations after progression on CDK4/6 inhibitors, single-agent ...
A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...
Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have improved survival following immunotherapy compared to patients without ...